🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The goal of this clinical trial is to compare a short course of antibiotics...
Status
Unknown
Location
University Hospitals Leuven
Start Date
2024-02-26
Trial ID
NCT05926063
Treatments Being Tested
This is a Phase I, Single-Center, Open-Label study evaluating the safety an...
Status
Completed
Location
Advanced Pharma CR, LLC
Start Date
2025-01-21
Trial ID
NCT06806995
Treatments Being Tested
The study plans to randomize a total of 240 patients infected with Gram-neg...
Status
Terminated
Location
University of Florida
Start Date
2021-12-17
Trial ID
NCT05102162
* To assess the safety and tolerability of single and multiple ascending in...
Status
Completed
Location
Multiple Locations
Start Date
2013-10-10
Trial ID
NCT03685084
Treatments Being Tested
The Infectious Diseases Society of America (IDSA) 2012 guidelines for the d...
Status
Terminated
Location
Loyola University Medical Center
Start Date
2014-03-19
Trial ID
NCT02168816
Treatments Being Tested
Study to evaluate the safety, tolerability and pharmacokinetics of multiple...
Status
Completed
Location
Quintiles
Start Date
2016-03
Trial ID
NCT02707107
Treatments Being Tested
This pilot study will compare clinical outcomes among patients treated with...
Status
Not Yet Recruiting
Location
Oregon Health & Science University
Start Date
2026-03
Trial ID
NCT07318584
Treatments Being Tested
Based on the current literature, investigators hypothesize that patients wi...
Status
Terminated
Location
University of Louisville
Start Date
2014-03-06
Trial ID
NCT02099240
Treatments Being Tested
Phase 2, randomised, double-blind, 2-cohort study in hospitalised adults wi...
Status
Completed
Location
Kromerizska nemocnice
Start Date
2017-09-05
Trial ID
NCT03680612
Treatments Being Tested
Phase 3 study to evaluate the efficacy and safety of cefepime/nacubactam or...
Status
Completed
Location
Meiji Research Site
Start Date
2023-05-23
Trial ID
NCT05887908